GHO Capital expands healthcare reach with €2.5bn Fund IV close
GHO Capital has closed its fourth fund, GHO Capital IV LP, raising over €2.5bn (~US$2.9bn) to invest in global healthcare. The fund brings the firm’s total assets under management to around €9bn, making it Europe’s largest healthcare-focused private equity firm.
GHO Capital ‘s Fund IV attracted capital from more than 30 new institutional investors across Europe, North America, Asia Pacific, and the Middle East, alongside continued support from existing backers. At 25% larger than GHO Capital Fund III, which closed in 2021, the fund represents a significant expansion of GHO’s investment capacity.
GHO focuses on scaling regional healthcare leaders into vertically integrated platforms, targeting sectors such as BioPharma, MedTech, HealthTech, Life Science Tools & Diagnostics, and Advisory & Data.
In 2025, GHO completed three new platform investments and several add-on acquisitions. These include Avid Bioservices Inc, a contract development and manufacturing organization (CDMO) specialising in the development and CGMP manufacturing of biologics; Scientist.com, an AI-powered R&D marketplace connecting researchers with over 6,000 suppliers and 1,000+ research services; and FotoFinder Systems, a leader in skin imaging systems offering advanced solutions for dermatology, plastic surgery, and clinical research.
adobe stock photos - Jiraporn 
Adcytherix SAS
wikipedia - PyMOL rendering of PDB